| Term 
 | Definition 
 
        | CH 11 Antihypertensive Agents α2 agonists   
| stimulates α2 adrenoceptors in vasomotor center; lowers TPR | depression, drowsiness, dry mouth, impaired ejaculation, false positive Coombs test, orthostatic hypotension  | Primarily used for hypertension during pregnancy |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 11 Antihypertensive Agents α2 agonists   
| Activate α2 adrenoceptors; reduces CO due to ↓HR and relaxation of capacitance vessels | Dry mouth, sedation, depression, Drowsiness Impaired ejaculation | *Sudden withdrawal may lead to a hypertensive crisis* |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 11 Antihypertensive Agents Ganglionic Blocker   
| Nonselective and noncompetitive antagonist of the nicotinic acetylcholine receptors | Severe orthostatic hypotension, constipation. | For very severe refractory hypertension |      |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 11 Antihypertensive Agents Effectors of post-ganglionic neuron/ Sympathetic nerve terminal blockers   
| Depletes catecholamines from peripheral and central neurons, probably by interfering with VMAT | depression, drowsiness diarrhea, impaired ejaculation sedation, rare parkinsonism symptoms |   |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 11 Antihypertensive Agents Effectors of post-ganglionic neuron/ Sympathetic nerve terminal blockers    
| Depletes catecholamines from peripheral neurons; does not enter CNS | orthostatic hypotension, diarrhea, impaired ejaculation |   |    |  | 
        |  | 
        
        | Term 
 
        | Prazosin Terazosin Doxazosin |  | Definition 
 
        | CH 11 Antihypertensive Agents Alpha 1 Blockers    
| Block α1 receptors on vasculature, inhibits vasoconstriction | first dose effect - orthostatic hypotension after first few doses | Hypertension, benign prostatic hyperplasia  |          |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 11 Antihypertensive Agents Beta Blockers   
| blocks both β1 and β2 receptors; β1 blockade decreases rate and force of heart contraction, ↓ CO | bradycardia, asthmatic attack, altered taste, fatigue with exercise, bronchoconstriction, depression, worsen Reynaud’s, decrease HDL, increase triglycerides | also used for angina, arrhythmias, migraine, stage fright |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 11 Antihypertensive Agents Beta Blocker   
| β1 selective blocker, partial agonist Lower BP and HR | all of these more selective β1 blockers can cause bradycardia and fatigue, but do not have the β2 effects (e.g. worsening asthma and diabetes)   | Hypertension, arrhythmias, migraine |    |  | 
        |  | 
        
        | Term 
 
        | Betaxolol and many other "olol"s |  | Definition 
 
        | CH 11 Antihypertensive Agents Beta Blockers   
| β1 selective blocker Lower HR and BP, reduce renin, may be safer in asthma | Bradycardia, fatigue, vivid dreams, cold hands | Hypertension, angina pectoris, arrhythmias |  
|   | *All of these more selective β1 blockers can cause bradycardia and fatigue, but do not have the β2 effects (e.g. worsening asthma and diabetes)* |   |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 11 Antihypertensive Agents Direct-Acting Vasodilator   
| open K+ channels in vascular smooth muscle; dilates arterioles | hair growth (hirsutism),edema, cardiac tamponade, pigmentation changes | Rogaineoral med
 |      |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 11 Antihypertensive Agents Direct-Acting Vasodilator    
| causes formation of cyclic GMP; nitric oxide release; dilates arterioles but not veins |   lupus-like syndrome after high doses or in slow acetylators | does not dilate coronary arteries, may actually compromise blood flow to the heart; oral med |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 11 Antihypertensive Agents Direct-Acting Vasodilator   
| open K+ channels in vascular smooth muscle; parenteral | decreases insulin secretion hyperglycemia | given IV; hypertensive emergencies |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 11 Antihypertensive Agents Direct-Acting Vasodilator   
| Causes formation of cyclic GMP. Dilates both arteries and veins |  cyanide poisoning | DOC in hypertensive emergencies. Must be constituted just before use; given IV |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 11 Antihypertensive Agents Direct-Acting Vasodilator   
| Agonist of dopamine D1 receptors resulting in dilation of peripheral arteries and natriuresis | Reflex tachycardia, headache, flushing, ↑ intraocular pressure | Hypertensive emergencies and postoperative hypertension |    |  | 
        |  | 
        
        | Term 
 
        | Nifedipine and other "ipine"s |  | Definition 
 
        | CH 11 Antihypertensive Agents Calcium Channel Blocker   
| block calcium channels in vasculature; reduce vascular resistance | adverse cardiovascular events | verapamil, diltiazem have more cardiac effects, can be used as antiarrhythmics |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 11 Antihypertensive Agents Calcium Channel Blocker   
| Calcium channel blocker, dilates blood vessels |   | Hypertension, angina pectoris, arrhythmia |    |  | 
        |  | 
        
        | Term 
 
        | Captopril and other "pril"s |  | Definition 
 
        | CH 11 Antihypertensive Agents Angiotension Converting Enzyme (ACE) inhibitors   
| Inhibit angiotensin converting enzyme; reduces angiotensin II levels, ↓ vasoconstriction and aldosterone secretion, increases bradykinin (vasodilator) | Fetal abnormalities Angioneurotic edema Altered taste Dry cough | Hypertension, heart failure |    |  | 
        |  | 
        
        | Term 
 
        | Losartan and other "artan"s |  | Definition 
 
        | CH 11 Antihypertensive Agents Angiotension RecepTor ANtagonists   
| blocks angiotensin II receptors on vasculature, and blocks aldosterone secretion; no increase in bradykinin | Fetal abnormalities | Hypertension, heart failure |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 11 Antihypertensive Agents Renin Inhibitor   
| Inhibits enzyme activity of renin, reduces angiotensin I and II and aldosterone | Hyperkalemia, renal impairment, potential teratogen | Hypertension  |    |  | 
        |  |